Henry Schein, Inc. (NASDAQ:HSIC) Position Reduced by Handelsbanken Fonder AB

Handelsbanken Fonder AB trimmed its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 10.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 104,117 shares of the company's stock after selling 12,398 shares during the period. Handelsbanken Fonder AB owned 0.08% of Henry Schein worth $7,883,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of HSIC. McGlone Suttner Wealth Management Inc. purchased a new position in Henry Schein in the 4th quarter valued at about $39,000. Baystate Wealth Management LLC increased its position in shares of Henry Schein by 2,500.0% during the third quarter. Baystate Wealth Management LLC now owns 520 shares of the company's stock worth $39,000 after purchasing an additional 500 shares in the last quarter. Neo Ivy Capital Management acquired a new position in Henry Schein in the 3rd quarter valued at $46,000. Covestor Ltd lifted its holdings in Henry Schein by 22.8% in the 3rd quarter. Covestor Ltd now owns 1,367 shares of the company's stock valued at $102,000 after purchasing an additional 254 shares in the last quarter. Finally, Fifth Third Bancorp boosted its stake in Henry Schein by 14.3% during the 3rd quarter. Fifth Third Bancorp now owns 1,744 shares of the company's stock worth $129,000 after purchasing an additional 218 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Insiders Place Their Bets

In other news, CEO Bradford C. Connett sold 6,430 shares of the firm's stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares of the company's stock, valued at $5,430,462.24. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other news, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the sale, the chief executive officer now directly owns 73,108 shares in the company, valued at $5,430,462.24. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the business's stock in a transaction on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the transaction, the insider now directly owns 209,562 shares of the company's stock, valued at $15,585,125.94. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Henry Schein Trading Down 0.5 %

Shares of HSIC stock traded down $0.39 during trading hours on Thursday, hitting $72.82. The company had a trading volume of 583,100 shares, compared to its average volume of 1,083,980. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.67 and a quick ratio of 1.00. The stock has a market capitalization of $9.36 billion, a PE ratio of 23.02, a price-to-earnings-growth ratio of 1.80 and a beta of 0.87. The company's fifty day moving average is $74.28 and its 200 day moving average is $72.43. Henry Schein, Inc. has a fifty-two week low of $60.01 and a fifty-two week high of $83.15.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Tuesday, February 27th. The company reported $0.66 EPS for the quarter, missing analysts' consensus estimates of $0.70 by ($0.04). The firm had revenue of $3.02 billion for the quarter, compared to analyst estimates of $3 billion. Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The firm's revenue for the quarter was down 10.5% on a year-over-year basis. During the same quarter last year, the company earned $1.21 earnings per share. Research analysts expect that Henry Schein, Inc. will post 5.07 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have recently weighed in on HSIC shares. Barrington Research raised their price target on shares of Henry Schein from $82.00 to $90.00 and gave the stock an "outperform" rating in a research note on Wednesday, February 28th. Piper Sandler boosted their target price on Henry Schein from $78.00 to $86.00 and gave the stock an "overweight" rating in a report on Monday, February 26th. SVB Leerink started coverage on Henry Schein in a research report on Monday, February 26th. They issued a "market perform" rating and a $78.00 price target for the company. Leerink Partnrs reiterated a "market perform" rating on shares of Henry Schein in a research report on Monday, February 26th. Finally, Jefferies Financial Group upped their target price on Henry Schein from $74.00 to $81.00 and gave the company a "hold" rating in a report on Wednesday, March 6th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $81.09.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.